Pre Seed · Medtech & Devices · Munich, Germany · Founded 2023 · 3–5 employees
Sedivention is developing a revolutionary minimally invasive medical device called the 'Blizzard Balloon' that treats obesity through a 20-minute outpatient cryoablation procedure targeting the vagus nerve branches that transmit hunger signals from the stomach to the brain. The startup secured €800,000 in pre-seed funding from High-Tech Gründerfonds in November 2024 and has won multiple startup competitions including BayStartUP Munich Business Plan Competition. Their novel approach offers a scalable alternative to invasive bariatric surgery, addressing a global market projected to reach 1.5 billion severely obese people by 2030.
No open roles listed right now.